The most important one, miR-146a5, which targets PMAIP1, NUMB, ERBB4, IRAK1 and CCL5 genes that are related to the development and morphogenesis of the heart muscle, was found to effectively distinguish cases of foetal VSD from controls. This evidence concerns the gene CCL5 and ventricular septal defect.